Induction Carboplatin

DRUG2 trials

Sponsors

Radiation Therapy Oncology Group, Nir Peled

Conditions

Lung CancerNSCLC (non-small Cell Lung Cancer)

Phase 2

Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

CompletedNCT00096226

Radiation Therapy Oncology GroupLung Cancer

Start: 2004-09-30End: 2016-05-16Updated: 2019-09-18

First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy

RecruitingNCT06667167

Nir PeledNSCLC (non-small Cell Lung Cancer)

Start: 2024-12-24End: 2028-11-01Target: 21Updated: 2025-01-17